TrialBMC gastroenterology2025

A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.

Celine Tack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.